Indunil Karunarathna: Kawasaki Disease at the Intersection of Immunology, Cardiology, and Vascular Biology
Indunil Karunarathna, Founder of Uva Clinical Research Lab (UCRL), shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Kawasaki disease is a unique pediatric inflammatory disorder that occupies a critical intersection between immunology, cardiology, and vascular biology.
Although classically described as an acute, self-limited febrile illness of childhood, it is now understood to be a complex immune-mediated vasculitis with the potential for lifelong cardiovascular consequences.
The disease process is driven by dysregulated innate and adaptive immune responses that target the vascular endothelium, particularly within the coronary arteries, leading to aneurysm formation, thrombosis, and long-term vascular remodeling.
Early diagnosis and timely immunomodulatory therapy, especially intravenous immunoglobulin, dramatically reduce morbidity and mortality, transforming outcomes from historically fatal to largely survivable.
However, survival does not equate to cure.
Even in patients whose coronary aneurysms regress, persistent endothelial dysfunction and vascular scarring confer long-term cardiovascular risk.
Kawasaki disease should therefore not be conceptualized as a transient pediatric illness, but rather as a lifelong cardiovascular condition originating in childhood, requiring structured acute management, long-term surveillance, and transitional care into adulthood.”
Title: Kawasaki Disease: An Immune-Mediated Vasculopathy with Lifelong Cardiovascular Consequences
Authors: Indunil Karunarathna, Prasan Gunasena, Kap Gunawardana, Sam Rajapaksha, Palith Aluthge, Asok Jayawardana, Cam Fernando, USG Vidanagama, UPN Ekanayake, TMB Hapuarachchi, Sach Senanayaka, Ban Rathnayak, AN Thilak Warnakulasooriya, Palinda Athulgama, Mud Abeyek, San Dius, Ram Ranwala, Sanj Godage, Suni Senadeera, Jaga Wijepala, Neha Perera, Sena Gunathilake, Kap De Alvis, PNG Rodrigo
Read the Full Article on Uva Clinical Anaesthesia and Intensive Care
Other posts featuring Indunil Karunarathna on Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention